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Overview of Translational Biomedical Research 
 and the UMass Center for Clinical & 
Translational Science 
 
John L. Sullivan, MD  
Professor of Pediatrics and Molecular Medicine 
Director, UMass Center for Clinical Translational Science 
Vice Provost for Research 
The UMass CTSA Grant  
 On July 14, 2010, the University received a 5-year, $20 million 
Clinical and Translational Science Award from the NIH 
 
 Joins an elite consortium of 60 nationally prominent research 
institutions 
 
 Terry Flotte, MD, Dean of the School of Medicine, and John 
Sullivan, MD, Vice Provost for Research at the Medical School 
serve as Co-Principal Investigators on the grant  
 
 Partners include the UMass campuses, UMass Memorial Health 
Care, Commonwealth Medicine, MassBiologics, Abbott 
Bioresearch Center, Charles River Labs, New England Regional 
Translational Network and WPI 
 
UMCCTS – Primary Goals  
 Accelerate early phase clinical trials by recruiting and supporting clinical research 
leaders, establishing innovative research support facilities and developing new 
therapeutics based on UMass discoveries 
 
 Integrate unique networks of clinical research and health care delivery in central 
New England and throughout Massachusetts to expand later phase clinical trials 
 
 Build collaboration among the three schools of UMMS and across the five UMass 
campuses in developing programs, curricula and faculty support systems that foster 
and promote careers in clinical and translational research 
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The UMCCTS includes faculty, staff, and students at all 5 UMass campuses 
John Sullivan, Director* 
Nate Hafer, Director of Operations* 
 
 
 
UMCCTS External Advisory 
Committee 
Michael Collins, SVP for the 
Health Sciences 
UMCCTS Steering Committee 
Office of Global 
Health 
K. Luzuriaga*, D. 
Gallagher 
Center for 
Bioethics 
Participant 
Clinical 
Interactions 
M. Fox 
Regulatory 
Knowledge & 
Support 
S. Noone 
Research Integrity 
and Clinical 
Operations 
Director 
S. Noone* 
Medical Students 
Research Track 
P. Franklin 
Masters Clinical 
Investigation 
R. Goldberg 
PhD CPHR 
MD/PhD 
Millenium PhD 
C. Upshur, G. 
Szabo*, H. 
Kornfeld 
K12 Program 
K. Luzuriaga, D. 
Ziedonis 
Research Education, 
Training & Career 
Development 
Co-Directors 
A. Carruthers* & K. 
Luzuriaga* 
T1 
Bench to Bedside 
Co-Directors 
J. Sullivan* & T. Flotte* 
 
Novel 
Methodologies 
UMATC, M2D2 , 
CWM , MBL  
 
Research 
Integration Pilot 
& Collaborative 
Studies 
Translational 
Technologies & 
Resources 
T. Pederson, 
G. Schneider* 
T2+ 
Bedside to Patients 
and Community 
Co-Directors 
C. Kiefe* & J. Gurwitz 
Biostatistics, 
Epidemiology, & 
Research Design 
A. Ash 
Biomedical 
Informatics 
T. Houston*, Z. 
Weng 
Community 
Research & 
Engagement 
I. Ockene* 
Sumner Smith 
Grants Specialist 
Administrative 
Assistant 
Jean Cummiskey 
Communication & 
Evaluation* 
Evaluation 
Communication 
Operations Committee (members designated with an *) 
UMass Center for Clinical and Translational Science (UMCCTS) 
 
Biorepository 
T. Mayer 
J. Meisner 
Volunteer 
Recruitment Core 
M. Maynard 
 
UMCCTS Membership  
 Membership is open to all members of the UMass research community, 
provided that they are engaged in some aspect of clinical or translational 
research:  
 
 Over 300 colleagues from the campuses have already become members 
 
 Benefits of membership include: 
 
 Access to core facilities and services operated by, or affiliated with, the UMCCTS 
o In the case of cores operating on a fee-for-service basis on the Worcester 
campus, members will receive the on-campus faculty rate 
 Access to the Medical School Library, including on-line subscriptions  
 Participation in education, training and scientific programs sponsored by the 
UMCCTS 
 Opportunity to apply for pilot grant funding through the UMCCTS 
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Nate Hafer’s Job: 
 
To help you identify resources available 
through the CCTS and understand how these 
resources can benefit your research  
 
nathaniel.hafer@umassmed.edu 
508-856-2511 
http://www.umassmed.edu/cts/index.aspx 
  
Pilot Project Program 
Specific Aims: 
1. Stimulate the development of new clinical and translational 
inter- and multi-disciplinary teams 
2. Provide novel support mechanisms for junior investigators 
3. Increase the emphasis on pilot funding for community-
engaged research 
4. Develop new methodologies to leverage institutional 
strengths and new initiatives 
5. Pursue high-risk, high reward studies 
6. Support projects utilizing the unique core facilities at the 
medical school and throughout the University 
7. Encourage collaboration across the five UMass campuses 
1. Life Sciences Moment Fund   $1.5M 
 
2. Pilot Project Program   $2.1 M 
 
3. WPI/UMMS Collaborative Pilot Project Program   $600K 
UMCCTS Pilot Grant Programs 
2009-2011 
2010 Life Sciences Moment Fund Recipients  
(3rd Funding Cycle) 
UMMS Collaborator(s)/Dept UMass Collaborator/Dept Project Title 
Patricia Franklin, MD, MPH, MBA 
Joy McCann Professor 
Patty S. Freedson, PhD 
Professor and Chair, Kinesiology 
Amherst campus 
Technology to assess physical activity and 
sedentary behavior in aging adults with 
osteoarthritis 
Alonzo Ross, PhD 
Professor, Biochemistry and Molecular 
Pharmacology 
Phillip Zamore, PhD 
Professor, Biochemistry and Molecular 
Pharmacology 
Lisa Minter, PhD 
Assistant Professor, Department of 
Veterinary and Animal Sciences 
Amherst campus 
Targeting microRNAs to Enhance a Novel 
Therapy for Glioblastomas 
Gary Ostroff, PhD 
Professor of Molecular Medicine 
Hardy Kornfeld, MD 
Professor of Medicine  
Gregory N. Tew, PhD 
Associate Professor, Polymer Science & 
Engineering 
Amherst campus 
Targeted Delivery of Novel Antimicrobial 
Peptide Mimics to TB 
Celia Schiffer, PhD 
Professor, Biochemistry & Molecular 
Pharmacology 
Margaret Riley, PhD 
Professor of Biology 
Amherst campus  
Testing novel antimicrobials to treat chronic 
Pseudomonas aeruginosa infections in CF 
lung 
Andrew Karellas, PhD 
Professor of Radiology 
David Medich, PhD 
Director, Radiation Safety 
Peter Gaines, PhD 
Assistant Professor, Molecular and 
Developmental Biology /Lowell campus 
Feasibility of Contrast Enhanced Neutron 
Imaging for the Early and Accurate 
Detection of Disease 
Education, Training, and Career Development 
Our goal is to expand the critical mass of expert scientists 
undertaking clinical and translational research by training 
healthcare professionals, basic scientists, junior faculty, 
postdoctoral fellows, graduate students, nursing students, 
medical students and research associates in the 
principles and practices of clinical and translational 
research.  
 
UMCCTS – Faculty Development - KL2 Scholar 
Recipient Mentors 
Olga Hardy, MD 
Department of Pediatrics 
 
Drs. Czech  and Lee 
 
 
Wendy Marsh, MD  
Department of Psychiatry 
Drs. Nicholson and Rothschild 
 
 
Jeff Bailey, MD, PhD  
Department of Medicine, 
Program in Bioinformatics and Integrative Biology 
Drs. Finberg and Weng 
 
 
Sarah Cutrona,  MD, MPH  
Department of Medicine 
Drs. Gurwitz and Mazor 
 
 
Heena Santry, MD 
 Department of Surgery 
Drs. Kiefe and Messina 
 
 
1. Quantitative Health Sciences Department – Quantitative Methods Core 
Biostatistics/Epidemiology/Study Design 
 
2. Biomedical Informatics 
 
3. Conquering Diseases Clinical Research Center 
 
4. Conquering Diseases Biorepository and Research Volunteer 
Recruitment Core 
 
5. Deep Sequencing Core 
 
6. Proteomics Core 
UMCCTS Core Infrastructure 
Massachusetts Integrated Clinical Academic  
Research Database (MICARD) 
 Serves as an online catalogue for the Conquering Diseases 
Biorepository 
  
 Offers a de-identified view of clinical phenotypes of UMMHC 
patients and their consented bio-samples 
 
 These data will be most useful for investigators interested in:  
 Generating new research hypotheses  
 Preparing grant applications that would benefit from pre-
identification and/or characterization of a potential research 
cohort  
 Identifying potential cohorts for clinical trials  
 Identifying consented biosamples from the UMMS Conquering 
Diseases Biorepository  
 
 MICARD warehouse contains data on more than 2 million patients 
 
Conquering Diseases Biorepository Core  
 A new resource for banking blood samples for 
biomedical research 
 Will store plasma, DNA and RNA 
– RNA storage a differentiating aspect 
of the Biorepository and reflects the 
world-class strength of the medical 
school’s RNA research community  
 Provide researchers with a pool of de-
identified samples to work with 
– Information about patients’ age, 
gender, diagnoses and medications, 
allowing for comparison of one 
sample to the next 
 Biorepository samples are collected from 
members of the community who support 
biomedical research by giving their 
consent, rather than being obtained as 
discarded blood samples 
 This approach allows nearly all 
specimens to reach thermal 
preservation within 1 hour of 
collection 
Conquering Diseases Clinical  
Research Center 
 Offers investigators the space, staff and resources to 
conduct their clinical studies and trials efficiently 
 
 Welcoming area for study subjects, the CRC comprises 
5,000 sq ft, including 6 exam rooms, 3 infusion bays, a 
small laboratory for packaging & shipping specimens, 
conference room space for monitor and study initiation 
visits, and touch-down space for visiting staff and 
investigators 
 
 Staff includes a research nurse manager, four 
experienced research nurses, two investigational 
pharmacists, a regulatory support coordinator and a 
receptionist/administrative assistant 
Research Integrity and Clinical 
Operations 
 
 
 Create central hub for Clinical Research Resources and 
Regulatory Knowledge & Support 
 
 Ensure clinical researcher best practice (‘GCP’) by 
promoting enhanced knowledge and skills  
 
 Enhance institutional knowledge and support: ensuring best 
practice is shared responsibility  
 
 Continuing Education & Training 
  
 New Certificate in Clinical Research Management: 
 
 CCTS and Graduate School of Nursing; CEU-based 
 Deepen regulatory knowledge for  FDA-regulated trials and 
translational research; strengthen support for investigator-
initiated research 
 Started March 2011 
 Cost $350 – includes contact hours and book 
 Co-directors: Sheila Noone & Carol Bova 
 http://www.umassmed.edu/news/research/2011/human_trials.aspx 
Research Integrity and Clinical 
Operations 
Center for Bioethics 
 Education, research, and consultation in bioethics are 
critical as the clinical research enterprise expands at 
UMMS/UMMHC  
 
 2 outstanding candidates have been accepted to the 
Fellowship Program in Medical Ethics at Harvard 
Medical School 
 
 The successful candidate(s) will play a key role in the 
development of a Center for Bioethics as part of the 
UMCCTS 

National Center for Advancing  
Translational Sciences  
October 2011 
 Highest Priority of NIH Director, Dr. Francis Collins 
 
 Focused on Rapidly Advancing Opportunities to Prevent and 
Treat Disease 
 
 Will Include National CTSA Network and Partnerships with FDA, 
Pharma and Biotech 
 
 Success Measured by Catalyzing Collaborations Between  
Basic Scientists and Physician Investigators 
National Center for Advancing  
Translational Sciences  
October 2011 
 Clinical and Translational Science Awards 
 
 Therapeutics for Rare and Neglected 
Diseases 
 
 Cures Acceleration Network ($100 Million) 
 
 Rapid Access to Intervention Development 
 
 Molecular Libraries Program 
Open Discussion and 
Questions 
